<HELP> for explanation

Блог им. gtcapital

SPY продолжает рост

Ближайший уровень поддержки по SPY – 198.50 уровень сопротивления – 199.10

Блог им. gtcapital: SPY продолжает рост

MUR покупка выше 68

APD смотрим на разворот вниз

EXP продажа при удержании 97

TRIP смотрим на покупку

XLNX покупка от 41

UIS покупка от 20

Gapping up/down: FB +9%, UA +5% and FFIV +2% after earnings, QRE +11% after M&A news, RKUS +2% after added to GS Conviction Buy list; ANGI -25% and GM -2% after earnings, SRPT -9% after terminating CSO, BA -1% after earnings

Gapping up
In reaction to strong earnings/guidance: VDSI +14.9%, LOGI +14.8%, QRE +11.3%, AGEN +9.8%, FB +9.2%, TDY +9%, FTNT +8.6%, SKX +8.4%, NOK +8.2%, UA +5.6%, EGHT +5.5%, HBI +5.2%, COG +4.7%, ORLY +4.4%, RJF +4%, PTEN +3.9%, ILMN +3.5%, JBLU +3.3%, NVEC +2.9%, POT +2.9%, INFN +2.8%, CRI +2.8%, UAL +2.2%, UAL +2.2%, FFIV +2%, IMAX +1.9%, SQNS +1.8%, MMM +1.8%, BMY +1.6%, HOT +1.5%, CAM +1.5%, CTXS +1.3%, ABC +1.3%, GILD +1.1%, NURO +1%.

M&A news: QRE +11.3% (to be acquired by Breitburn Energy Partners (BBEP)), ARIA +7.1% (attributed to a positive tweet that has since been deleted; Tweet was with regards to a SHPG for ARIA rumor).

Other news: APP +8.3% (disclosed details of new Board of Directors), DARA +8.1% (cont momentum), SPNC +7.4% (announces FDA clearance of peripheral laser atherectomy devices for in-stent restenosis ), TWTR +4.1% (following FB results), JMBA +3.8% (Engaged Capital disclosed 7.0% stake in SC 13D filing; believe the Issuer possesses multiple paths to value creation, expects to continue to have discussions with the Issuer's management), KNDI +2% (following yesterday's 12% decline), P +2% (following FB results), LNKD +1.3% (following FB results), FEYE +0.9% (on FTNT results), LL +0.9% (responded to lawsuit allegations, stating, «The allegations in this lawsuit concerning our product are simply flat-out false»)

Analyst comments: WIBC +3.4% (upgraded to Strong Buy from Outperform at Raymond James), RKUS +2.6% (added to Conviction Buy list at Goldman), UIS +1.4% (upgraded to Positive from Neutral at Susquehanna), ZFGN +0.6% (initiated with a Outperform at Leerink Partners)

Gapping down
In reaction to disappointing earnings/guidance: ANGI -25.1%, TRIP -10.1%, PLCM -5.3%, DNKN -5.1%, QCOM -4.4%, TQNT -4.3%, CRUS -4.3%, BBEP -3.1%, VAR -2.9%, GM -2.4%, MNRO -2.3%, ALXN -1.8%, DHI -1.7%, T -1.4%, ETFC -1.4%, TEX -1.4%, CAKE -1.3%, CAT -1.3%, TSCO -1.1%, SGMO -1%, TER -0.9%, BSX -0.9%, GPI -0.9%, CELG -0.8%, RDWR -0.6%.

M&A news: EGAS -3.2% (responds to press release issued by Algonquin Power & Utilities and reiterates rejection of their grossly inadequate, unsolicited offers), BBEP -3.1% (acquired QR Energy LP in a unit-for-unit exchange implying a transaction value of ~ $3.0 bln).

Other news: CALI -33.9% (co said it will vigorously oppose 'grossly unfair and damaging' plan by Depository Trust Company to impose 'global lock' on its securities), GPRC -13.2% (reported receipt of notice from DTC of plans to impose 'global lock' on its securities; company says DTC plans are 'unfair and unnecessarily damaging to current shareholders and is reviewing options'), SRPT -9.2% (discloses that Arthur Krieg, Senior Vice President and Chief Scientific Officer, was terminated from his position with the company), INCY -8.1% (also announces top-line results from RELIEF trial of ruxolitinib in patients with polycythemia vera; statistical significance not achieved for the primary endpoint of symptom control; positive trends in favor of ruxolitinib versus hydroxyurea observed), MHFI -7.6% (receives Wells Notice from SEC regarding S&P's rating of six commercial mortgage backed securities transactions in 2011), GOV -5.6% (prices 13.5 mln common shares at $23.50 per share), QUNR -1.9% (following TRIP results), INO -1.5% (files for $175 mln mixed securities shelf offering).

Только зарегистрированные и авторизованные пользователи могут оставлять комментарии.


....все тэги